Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Main Authors: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2006
|
Podobne knjige/članki
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
od: Mukhtyar, C, et al.
Izdano: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
od: Mukhtyar, C, et al.
Izdano: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
od: Saket Jha, et al.
Izdano: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
od: Zhi-Ying Li, et al.
Izdano: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
od: Mahmoud M. Mohamed, et al.
Izdano: (2023-07-01)